Peer Review History
| Original SubmissionNovember 24, 2024 |
|---|
|
Dear Dr. Podczarska-Głowacka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Julio Alejandro Henriques Castro da Costa Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have selected “Clinical Trial” as your article type. PLOS ONE requires that all clinical trials are registered in an appropriate registry (the WHO list of approved registries is at https://www.who.int/clinical-trials-registry-platform/network/primary-registries " https://www.who.int/clinical-trials-registry-platform/network/primary-registries and more information on trial registration is at http://www.icmje.org/about-icmje/faqs/clinical-trials-registration/ ). Please state the name of the registry and the registration number (e.g. ISRCTN or ClinicalTrials.gov) in the submission data and on the title page of your manuscript. a) Please provide the complete date range for participant recruitment and follow-up in the methods section of your manuscript. b) If you have not yet registered your trial in an appropriate registry, we now require you to do so and will need confirmation of the trial registry number before we can pass your paper to the next stage of review. Please include in the Methods section of your paper your reasons for not registering this study before enrolment of participants started. Please confirm that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered”. Please see http://journals.plos.org/plosone/s/submission-guidelines#loc-clinical-trials for our policies on clinical trials. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information . [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** Reviewer #1: Thank you for submitting your manuscript, which provides valuable insights into the effects of Nordic Hamstring Exercises on postural balance and muscle strength. Overall, the study is well-structured and contributes significantly to the field. However, there are a few areas where improvements can enhance the clarity and impact of your work. In the abstract, adding practical implications and briefly mentioning key methodological details such as sample size and statistical significance would strengthen its completeness. In the introduction, highlighting the innovative aspects of your study and better contextualizing the findings within the existing literature would further support the relevance of your work. The methods section could benefit from additional details regarding group balancing, the monitoring of exercise protocols, and a more explicit justification of the statistical methods used. In the results section, statistical significance could be emphasized more clearly in the tables, and the clinical relevance of the findings could be elaborated. The discussion would be strengthened by a more detailed examination of the study’s limitations, the generalizability of the findings, and suggestions for future research on the long-term effects of Nordic Hamstring Exercises. The conclusion could also expand on future research directions and discuss the broader implications of the findings on sports performance. Finally, the figures and tables could be made more user-friendly by improving visual elements such as scales and coloring, and adding explanatory notes. Ensuring consistency in reference formatting and providing more detailed explanations for methodological references would further improve the manuscript’s readability and coherence. Addressing these points will help enhance the overall quality and impact of your manuscript. Reviewer #2: General Overview Your research on how a 4-week Nordic Hamstring Exercise (NHE) program affects postural balance is timely and pertinent, considering how common hamstring injuries are in sports. The Biodex Balance System and the randomised controlled trial (RCT) design are noteworthy advantages, providing accurate and unbiased assessments of postural balance. The manuscript has to be significantly revised, nevertheless, in order to improve its organisation, clarity, and level of analysis. Specific Comments: 1. Introduction • The introduction highlights the importance of hamstring injury prevention and NHE, but the connection between NHE and postural balance could be more clearly articulated earlier. • A clearly defined research question or hypothesis would improve the focus and direction of the study. 2. Methodology • The use of two-way repeated measures ANOVA and Pearson correlation is appropriate, but further explanation of participant retention rates is needed. Were there any dropouts? How were they handled in the analysis? • Consider adding a gender-based analysis to explore potential differences in outcomes. • Extending the follow-up period beyond 4 weeks would provide insights into the long-term effects of NHE on postural balance. 3. Results • The results section is thorough, but more emphasis on gender-specific differences and their implications would enhance the analysis. • Clarify how retention rates or any missing data might have influenced the findings. 4. Discussion • The discussion effectively integrates your findings with previous research, but a more explicit identification of research gaps would strengthen the narrative. • Limitations are acknowledged, but consider elaborating on the impact of sample size, participant diversity, and previous injury history. 5. Bibliography/References • The references are relevant and comprehensive, but a tighter focus on NHE’s direct impacts on muscle balance, strength, and injury prevention would strengthen the evidence base. Ensure that all cited studies are directly related to the core research question. 6. Language and Presentation • Some sentences are dense and complex. Simplifying these will improve readability. • Grammar and flow require attention. Consider a professional language editing service if necessary. Ethical Considerations There are no apparent concerns regarding research or publication ethics. However, please ensure data availability and transparency for reproducibility. Recommendation Requires Major Revision Your manuscript's clarity, rigour, and impact will all be greatly enhanced by following these suggestions. Reviewer #3: The primary aim of this study is to compare the treatment group with the placebo group. However, the primary endpoint was not met, as no significant difference was observed between the groups. This point needs to be clarified in both the abstract and the conclusion. Further clarification is needed regarding the sample size. Was the sample size calculated specifically for between-group comparisons? What effect size was used for the calculation? Was it based on the between-group difference at 8 weeks or across all time points? Additionally, what is the beta? The chosen effect size and beta value must be clinically justified. On page 11, it would be more appropriate to move Table 1 and the participant information to the Results section. For Tables 2–4, it is unclear whether the p-values from the post-hoc analyses were adjusted. The authors also mention “p = 0.01” in the statistical methods section, suggesting the use of raw p-values but with a stricter cutoff. This requires clarification. The column p-value *** in Tables 2–4 are ambiguous. The footnote says “***- between-group differences between 8 weeks and 4 weeks; (p≤0.05).” . If I understand correctly, there should be two p-values for each outcome—one for the 8-week comparison and one for the 4-week comparison between NHE and CON. However, only a single p-value is presented for each outcome, which needs further explanation. What does "(p≤0.05)" mean here? Additionally, the purpose of the correlation analysis is unclear and appears to lack relevance to the primary aim of the clinical trial. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: GÖKHAN DELİCEOĞLU Reviewer #2: Yes: D. Kalidoss Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
<p>The influence of 4-week eccentric Nordic Hamstring Exercise training on postural balance and muscle strength: a randomized controlled trial PONE-D-24-47476R1 Dear Dr. Podczarska-Głowacka, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Julio Alejandro Henriques Castro da Costa Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: (No Response) ********** Reviewer #3: All my concerns are addressed. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-24-47476R1 PLOS ONE Dear Dr. Podczarska-Głowacka, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Julio Alejandro Henriques Castro da Costa Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .